Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820
Clinical trial NCT02739360 · TERMINATED
Trial details
- NCT number
- NCT02739360
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-04
- Primary completion
- 2017-12-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.